Selected Publications
Engineering safe anti-CD19-CD28ζ CAR T cells with CD8a hinge domain in serum-free media for adoptive immunotherapy.
Muthuvel M, Ganapathy T, Spencer T, Raikar SS, Thangavel S, Srivastava A, Martin S(2025)
Front Immunol 2025 May 9;16:1545549. doi: 10.3389/fimmu.2025.1545549. PMID: 40416968; PMCID: PMC12098533.
CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?
Ganapathy T, Radhakrishnan R, Sakshi S, Martin S (2023)
Cancer Immunol Immunother. 2023 Feb;72(2):277-286. doi: 10.1007/s00262-022-03260-y.
Engineering off-the-shelf universal CAR T cells: A silver lining in the cloud.
Muthuvel M, Srinivasan H, Louis L, Martin S (2022)
Cytokine. 2022 Aug;156:155920. doi: 10.1016/j.cyto.2022.155920.
Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A, Alexander SG, Martin S(2023)
Front Immunol. 2023 May 16;14:1114499. doi: 10.3389/fimmu.2023.1114499.